Table 2.
NUPR1 Expression Reported in Lung Cancer Cell Lines and Tissues
| Cell line/Cancer tissue | Expression (+/−) | Description | Reference |
|---|---|---|---|
| Non-small cell lung cancer tumors | + | Squamous cell carcinoma | (Guo et al., 2012) |
| Non-small cell lung cancer tumors | + | Adenocarcinoma | |
| Non-small cell lung cancer tumors | + | Adenosquamous carcinoma | |
| A549 | + | Carcinoma (ATCC® CCL-185) | (Y. Li et al., 2020; Mu et al., 2018) |
| SK-MES-1 | + | Derived from metastatic site: pleural effusion, squamous cell carcinoma (ATCC® HTB-58) | (Guo et al., 2012) |
| 95-D (PLA-801D) | + | Non-small Cell Lung Cancer | |
| NCI-H460 | + | Pleural effusion, large cell lung cancer (ATCC® HTB-177) | (Guo et al., 2012; Mu et al., 2018) |
| NCI-H1650 | + | Adenocarcinoma, bronchoalveolar carcinoma, derived from metastatic site: pleural effusion (ATCC® CRL-5883) | (Guo et al., 2012) |
| NCI-H1299 | + | Derived from metastatic site: lymph node, non-small cell lung cancer (ATCC® CRL-5803) | (Guo et al., 2012; Mu et al., 2018) |
| BEAS-2B | + | Virus transformed bronchial epithelial cells | (D. Chen et al., 2016) |
| - | (Mu et al., 2018) | ||
| Non-small cell lung cancer tumors | + | Uncharacterized | (Mu et al., 2018) |
| NCI-H209 | - | Derived from metastatic site: bone marrow, small cell lung cancer (ATCC® HTB-172) | |
| NCI-H441 | + | Papillary adenocarcinoma (ATCC® HTB-174) | |
| NCI-H446 | + | Derived from metastatic site: pleural effusion, small cell lung cancer (ATCC® HTB-171) | |
| NCI-H385 | - | Bronchiole; derived from metastatic site: alveolus, bronchioalveolar carcinoma, non-small cell lung cancer (ATCC® CRL-5807) | |
| NCI-H1155 | + | Derived from metastatic site: lymph node, non-small cell lung cancer (ATCC® CRL-5818) | |
| NHBE | - | Normal bronchial epithelial cells |